A medical supply company needed the manufacturing muscle to keep up with the growth strategy it hoped to implement.
MediCo* was a $40 million producer of devices and tests used by the bedside in hospitals. While MediCo was the clear technology leader, and the only provider of certain critical tests, revenue and profits had fallen short of aspirations.
Believing that the manufacturing costs were scale driven, MediCo's management had recently reduced prices on device x with no significant impact on volume. Moreover, the factory was running out of capacity, requiring major investment and significant disruption of the business.
The Bain team was given two objectives:
- develop a growth strategy that would grow MediCo to $1 billion in market capitalization
- evaluate the manufacturing strategy and recommend changes
For the manufacturing aspect of the work, Bain analyzed MediCo's plant capacity, technology platforms and outsourcing opportunities.
Bain's recommendations were reviewed with the MediCo Board of Directors at a two day off-site meeting and were 100 percent approved for immediate action.
By increasing capacity in the current plant, MediCo was able to avoid a costly new expansion plan and boost production significantly.
* We take our clients' confidentiality seriously. While we've changed their names, the results are real.